$BSVN

Bank7 Corp.

No enriched coverage for $BSVN in the last 7 days.

No SEC Form 4 filings for $BSVN in the last 30 days.

Med

Bank7 Corp. (NASDAQ:BSVN) Sees Significant Decline in Short Interest

Bank7 Corp. (NASDAQ:BSVN) experienced a significant 18.1% decline in short interest in April, dropping to 39,425 shares. The company recently surpassed earnings expectations, reporting an EPS of $1.25 against an estimated $1.01 and revenue of $26.16 million versus $23.63 million. Analysts generally maintain a "Buy" rating for BSVN with a consensus price target of $54.50.

Bank7 beats first quarter estimates on strong earnings, stock up 2%

Bank7 Corp. (NASDAQ:BSVN) reported strong first-quarter 2026 results, surpassing analyst estimates for both adjusted earnings per share and revenue. The bank's shares rose nearly 2% in after-hours trading following the announcement. Key highlights include record EPS, net income, and pre-provision pre-tax earnings, alongside an expanded net interest margin and robust capital ratios.

Here's Why Bank7 ( BSVN ) Could be Great Choice for a Bottom Fisher

Bank7 (BSVN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a ...